Fast Five Quiz: HR-Positive/HER2-Negative Breast Cancer

Winston W. Tan, MD


September 14, 2021

Of the approximately 200,000 cases of early-stage breast cancer diagnosed in the United States each year, 1 in 3 will eventually metastasize. In nearly half of these women, the first detectable distant site is bone. In patients with HR+/HER- breast cancer, disease spreads to the bone in about 70% of cases. Other common sites are the lungs and the liver, but breast cancer can also spread to almost any other part of the body, including the brain and skin.

Learn more about metastatic breast cancer.


Comments on Medscape are moderated and should be professional in tone and on topic. You must declare any conflicts of interest related to your comments and responses. Please see our Commenting Guide for further information. We reserve the right to remove posts at our sole discretion.